Wire Stories

Petrochemicals Global Market Report 2022: Growth in the Automobiles Industry Leading to Increased Demand for Petrochemicals – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Petrochemicals Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The…

IC Markets becomes Official Global Partner for Rugby World Cup Sevens

SYDNEY--(BUSINESS WIRE)--#Cfd--IC Markets, one of the world’s largest Forex CFD brokers, has announced today that…

Accenture to Acquire Romp to Boost Brand Transformation Capabilities and Advance Customer Experience Across Southeast Asia

Jakarta-based brand and experience agency will enhance Accenture Song’s creativity and brand thinking JAKARTA, Indonesia--(BUSINESS…

EV Industry Chain in Kaohsiung Achieves Greater Global Presence

KAOHSIUNG,Taiwan--(BUSINESS WIRE)--The global sales of electric vehicles (EV) are growing exponentially. To forge Kaohsiung an…

BioDuro-Sundia and X-Chem Enter Partnership to Launch DEL Services in China for the Discovery of New Small Molecule Drugs

SHANGHAI--(BUSINESS WIRE)--#DEL--BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International,…

Ai Fukuhara Became a Spokesperson of Japanese Electric Bed for Elderly Brand PLATZ

ONOJO, Japan--(BUSINESS WIRE)--In August 2022, the Japanese electric bed for elderly brand PLATZ (TOKYO:7813) announced…

Jake Hesson Named Underwriting Manager, Marine, as Berkshire Hathaway Specialty Insurance Enters Commercial Hull Market in Australasia

BOSTON & SYDNEY--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) today announced that it is expanding into…

VIQ Solutions and Law In Order Transform Court Cases Creating Efficiencies and Bolstering Collaboration

Comprehensive solution and services suite advances digital transformation across Australia PHOENIX, Ariz.--(BUSINESS WIRE)--VIQ Solutions Inc.…

ENHERTU® Approved in the U.S. as the First HER2 Directed Therapy for Patients with HER2 Low Metastatic Breast Cancer

Based on DESTINY-Breast04 results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU reduced risk of disease…